Scholar Rock Holding Corporation

Principal Scientist, Bioanalytical Specialist

Scholar Rock Holding Corporation • $175K — $225K *
Pharmaceuticals & Biotech
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • PhD in biochemistry, immunology, pharmaceutical sciences, or related field.
  • 7+ years of experience in the biopharmaceutical industry.
  • Experience with biologics and complex therapeutic modalities in clinical development.
  • Proven track record of CRO and external laboratory oversight.
  • Strong ability to manage multiple priorities in a fast-paced environment.

Responsibilities

  • Lead scientific and strategic initiatives for bioanalytical assays in clinical development.
  • Act as subject matter expert for assay validation, study conduct, and regulatory compliance.
  • Develop and execute bioanalytical strategies for clinical trials from Phase 1 to Phase 3.
  • Oversee CRO partnerships for clinical bioanalysis, including method transfer and data delivery.
  • Manage vendor selection and performance monitoring for bioanalytical activities.
  • Contribute to regulatory documents and provide scientific input for clinical studies.
  • Integrate bioanalytical data to influence development strategy and program decisions.

Benefits

  • Comprehensive healthcare coverage.
  • Flexible work schedule and remote work options.
  • Opportunities for professional development and training.
  • Collaborative work environment focused on rare disease research.
Full Job Description
Summary of Position:

Scholar Rock is seeking an accomplished and highly collaborative leader in clinical bioanalysis to join the Bioanalytical Sciences team as Principal Scientist, Bioanalytical Specialist to provide scientific and operational leadership across our clinical stage programs.

Reporting to the Head of Bioanalytical Sciences, this individual will serve as a bioanalytical subject matter expert for our clinical stage programs, by representing the bioanalytical team at clinical study team meetings and providing oversight of clinical bioanalysis activities at CROs, including assay validation, sample analysis, data delivery, issue resolution, and inspection readiness, supporting strategic initiatives within the Bioanalytical and Preclinical Sciences teams. The Principal Scientist will partner cross-functionally with key parters in Discovery, Biomarker Development, Clinical Pharmacology, Clinical Sciences, Clinical Operations, and Regulatory to align bioanalytical strategy and execution with clinical development plans, regulatory expectations, and key program decisions. This individual will establish priorities and drive bioanalytical execution across multiple clinical programs in a dynamic, fast-paced environment.

The successful candidate will have demonstrated the ability to lead bioanalysis across all clinical stages, CRO management, and issue resolution. They will collaborate cross-functionally and provide scientific, strategic, and operational leadership for outsourced bioanalytical activities supporting Scholar Rock's clinical-stage programs.

Position Responsibilities

  • Provide scientific and strategic leadership for clinical-stage bioanalytical assays, including pharmacokinetic (PK), pharmacodynamic (PD), biomarker, and immunogenicity assays.
  • Serve as the clinical bioanalysis subject matter expert for assay validation, study conduct, sample analysis, data interpretation, and regulatory compliance.
  • Execute integrated bioanalytical strategies that support first in human Phase 1 through Phase 3 clinical development programs.
  • Provide scientific and operational oversight of outsourced clinical bioanalysis at CROs and partner laboratories, including method transfer, validation, sample analysis, troubleshooting, and data delivery.
  • Support vendor selection, contracting, study start-up, performance monitoring, and risk mitigation for bioanalytical vendors.
  • Author, review, and provide SME input for bioanalytical sections of clinical and regulatory documents, including protocols, lab manuals, clinical study reports, investigator brochures, BLAs, and responses to health authority questions.
  • Contribute to interpretation and integration of PK, PD, biomarker, and immunogenicity data to inform dose selection, development strategy, and program decision-making.
  • Provide SME support for regulatory inspections, audits, and inspection-readiness activities related to clinical bioanalysis.
  • Present bioanalytical strategies, study updates, risks, and recommendations to project teams, governance committees, and senior leadership.
  • Stay current with emerging bioanalytical technologies, industry trends, and evolving regulatory expectations to continuously strengthen organizational capabilities.


Candidate Requirements

  • PhD in biochemistry, immunology, pharmaceutical sciences, or a related discipline with 7+ years of relevant biopharmaceutical industry experience.
  • Demonstrated experience supporting biologics or other complex therapeutic modalities across First in Human, early- and late-stage clinical development programs.
  • Experience providing scientific oversight of CROs, external laboratories, technology vendors, and/or academic collaborators.
  • Ability to work independently, manage multiple priorities, and drive complex scientific initiatives in a fast-paced, highly collaborative environment.
  • Passion for rare disease research and a commitment to translating rigorous science into meaningful benefits for patients.


$175,000 - $225,000 a year

About Scholar Rock Holding Corporation

Scholar Rock Holding Corporation is a clinical-stage biopharmaceutical company that focuses on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company's proprietary platform technology is based on the use of growth factor-binding proteins to selectively inhibit the activation of these signaling pathways in a variety of tissues. Scholar Rock's lead product candidate, SRK-015, is a highly specific inhibitor of the activation of the growth factor myostatin, which is involved in the regulation of muscle mass. The company is headquartered in Cambridge, Massachusetts and was founded in 2012.
Learn more about Scholar Rock Holding Corporation
Size
145 employees
Market Cap
$411.3 million
Industry
Net Income
-$86.4 million
Founded
2012
5 Year Trend
+118.4%
Revenue
$15.4 million
NASDAQ

Similar Jobs

More Jobs at Scholar Rock Holding Corporation

More Pharmaceuticals & Biotech Jobs

Find similar Principal Scientist, Bioanalytical Specialist jobs: